GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Urteste SA (WAR:URT) » Definitions » EV-to-EBIT

Urteste (WAR:URT) EV-to-EBIT : -24.55 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Urteste EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Urteste's Enterprise Value is zł110.63 Mil. Urteste's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was zł-4.51 Mil. Therefore, Urteste's EV-to-EBIT for today is -24.55.

The historical rank and industry rank for Urteste's EV-to-EBIT or its related term are showing as below:

WAR:URT' s EV-to-EBIT Range Over the Past 10 Years
Min: -43.69   Med: -20.95   Max: -14.41
Current: -22.81

During the past 5 years, the highest EV-to-EBIT of Urteste was -14.41. The lowest was -43.69. And the median was -20.95.

WAR:URT's EV-to-EBIT is ranked worse than
100% of 425 companies
in the Biotechnology industry
Industry Median: 9.61 vs WAR:URT: -22.81

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Urteste's Enterprise Value for the quarter that ended in Mar. 2024 was zł105.27 Mil. Urteste's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was zł-4.51 Mil. Urteste's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.28%.


Urteste EV-to-EBIT Historical Data

The historical data trend for Urteste's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Urteste EV-to-EBIT Chart

Urteste Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -43.42 -21.76 -26.71

Urteste Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.14 -25.37 -22.51 -26.71 -

Competitive Comparison of Urteste's EV-to-EBIT

For the Biotechnology subindustry, Urteste's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Urteste's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Urteste's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Urteste's EV-to-EBIT falls into.



Urteste EV-to-EBIT Calculation

Urteste's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=110.626/-4.506
=-24.55

Urteste's current Enterprise Value is zł110.63 Mil.
Urteste's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-4.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Urteste  (WAR:URT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Urteste's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-4.506/105.2693
=-4.28 %

Urteste's Enterprise Value for the quarter that ended in Mar. 2024 was zł105.27 Mil.
Urteste's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-4.51 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Urteste EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Urteste's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Urteste (WAR:URT) Business Description

Traded in Other Exchanges
N/A
Address
ul. Starodworska 1, Gdansk, POL, 80-137
Urteste SA specialises in the development of technology allowing the detection of cancers at the early stages of their development.

Urteste (WAR:URT) Headlines

No Headlines